A think tank report has been published ahead of the UK government’s autumn statement, calling for a reform of R&D tax credits.
According to the report from Onward - which calls itself a center-right think tank - R&D tax credits must be reformed, not cut back, if the UK is to become an ‘innovation nation’.
"We have been working with our partners to call for the government to maintain existing commitments to raise public R&D investment"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze